Researchers at The Jackson Laboratory in Connecticut and MIT have developed a microneedle patch that samples immune cells living permanently in skin tissue—cells that blood tests routinely miss.
The device features hundreds of tiny projections that penetrate the epidermis to reach the dermis without causing pain or bleeding. A hydrogel coating made from biocompatible polymers derived from seaweed absorbs interstitial fluid from skin tissue, capturing resident memory T cells that act as immune sentinels.
Here's why this matters: these tissue-resident immune cells mount rapid responses to previously encountered threats like viruses or allergens, but they circulate sparsely in the bloodstream. Traditional blood draws and biopsies miss much of this critical immune activity.
"Blood tests and biopsies remain essential diagnostic tools," said Sasan Jalili, a biomedical engineer and immunologist at JAX who led the work. But for many applications—monitoring vaccine responses, tracking cancer therapy effectiveness, studying autoimmune skin conditions—sampling tissue-resident cells provides information that standard diagnostics overlook.
The patch delivers results within minutes for inflammatory signals and hours for immune cell collection. It proves especially valuable for patients difficult to draw blood from: infants, frail elderly individuals, and those needing samples from sensitive facial areas where biopsies would cause scarring.
When these resident T cells encounter familiar antigens (virus fragments or allergens), they "sound the alarm," attracting specialized T cells from the bloodstream to the patch site. This natural immune recruitment makes the patch a kind of immune activity detector.
The team—which included collaborators from University of Massachusetts Chan Medical School and the Ragon Institute—has already conducted initial human testing at UMass Chan. That's remarkably fast for moving from laboratory innovation to human studies, a transition that typically requires years.
Potential applications extend beyond monitoring vaccine and infection responses. The technology could help track vitiligo, psoriasis, and allergic dermatitis, investigate age-related skin changes and chronic inflammation in older adults, and potentially adapt to oral and nasal cavity immune monitoring.
The research team acknowledges that "additional studies to determine how the patch performs across different diseases and patient populations are under way." For patients with unpredictable condition flare-ups, future at-home monitoring using patches like this could provide real-time immune status without clinic visits.
This is a nice example of medical innovation that makes diagnostics less invasive while capturing information previously inaccessible without surgery. Elegant, practical, and addressing a real clinical need.
